SLC7A5 is highly expressed in the breast cancer cell lines MCF-7 and MDA-MB-231 [43,44], with higher upregulation in MCF-7 cells than in MDA-MB-231 cells [44]. Here, SLC7A5 is linked to breast carcinoma.